Aciphex - Anti-Inflammatory Drug?

For Helicobacter pylori -positive duodenal biological process, a operation of a PPI and 2 antibacterials will eradicate H. pylori in over 90% of cases and significantly reduce ulcer recurrence.
Patients with H. pylori -positive gastric ulcers should be managed similarly.
PPIs also have efficacy advantages over ranitidine and misoprostol and are bettor tolerated than misoprostol in patients taking nonsteroidal anti-inflammatory drugs (NSAIDs).
In endoscopically proven gastro-oesophageal ebb disease, cubage unit daily doses of the PPIs are more effective than H2-receptor antagonists for healing, and patients should receive a 4 to 8 week course of instruction of direction.
For severe pathology, with ulcer and/or unfavorable judgment activity, a higher dose regimen (omeprazole 40 mg, lansoprazole 60 mg, pantoprazole 80 mg or rabeprazole 40 mg daily) appears to income bettor healing rates.
There is little grounds that PPIs lead to subsidence of Barrett’s oesophagus or a diminution of subsequent adenocarcinoma ontogenesis, but PPIs are indicated in healing of any associated ulcer.
This is a part of article Aciphex - Anti-Inflammatory Drug? Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog